Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update

Less than one third of patients who suffer from major depressive disorder (MDD) report remission following antidepressant treatments requiring more diverse treatment approaches. Augmentation of second generation antipsychotics (SGAs) has been increasingly recognized as an important treatment option....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chonnam Med J
Main Authors: Wang, Sheng-Min, Han, Changsu, Lee, Soo-Jung, Jun, Tae-Youn, Patkar, Ashwin A, Masand, Prakash S, Pae, Chi-Un
Formato: Artigo
Idioma:Inglês
Publicado em: Chonnam National University Medical School 2016
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040765/
https://ncbi.nlm.nih.gov/pubmed/27689026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2016.52.3.159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados